OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives
Donovan McGrowder, Fabian Miller, Kurt Vaz, et al.
Brain Sciences (2021) Vol. 11, Iss. 2, pp. 215-215
Open Access | Times Cited: 105

Showing 1-25 of 105 citing articles:

Glial Cell-Mediated Neuroinflammation in Alzheimer’s Disease
Nour F. Al-Ghraiybah, Junwei Wang, Amer E. Alkhalifa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10572-10572
Open Access | Times Cited: 90

Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
Angelica Varesi, Adelaide Carrara, Vitor Gomes Pires, et al.
Cells (2022) Vol. 11, Iss. 8, pp. 1367-1367
Open Access | Times Cited: 75

Biomarkers for parkinsonian disorders in CNS-originating EVs: promise and challenges
Suman Dutta, Simon Hornung, Hash Brown Taha, et al.
Acta Neuropathologica (2023) Vol. 145, Iss. 5, pp. 515-540
Open Access | Times Cited: 57

The Role of TDP-43 in Neurodegenerative Disease
Yan-Zhe Liao, Jing Ma, Jie-Zhi Dou
Molecular Neurobiology (2022) Vol. 59, Iss. 7, pp. 4223-4241
Closed Access | Times Cited: 51

Increased levels of the synaptic proteins PSD-95, SNAP-25, and neurogranin in the cerebrospinal fluid of patients with Alzheimer’s disease
Pia Kivisäkk, Becky C. Carlyle, Thadryan Sweeney, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 47

Understanding neuropsychiatric symptoms in Alzheimer’s disease: challenges and advances in diagnosis and treatment
Andrew Pless, Destany Ware, Shalini Saggu, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 40

Emergence of Extracellular Vesicles as “Liquid Biopsy” for Neurological Disorders: Boom or Bust
Ashish Kumar, Michael A. Nader, Gagan Deep
Pharmacological Reviews (2023) Vol. 76, Iss. 2, pp. 199-227
Open Access | Times Cited: 30

Automated Classification of Brain Tumors from Magnetic Resonance Imaging Using Deep Learning
Zahid Rasheed, Yong-Kui Ma, Inam Ullah, et al.
Brain Sciences (2023) Vol. 13, Iss. 4, pp. 602-602
Open Access | Times Cited: 27

Amyloid-β and Phosphorylated Tau are the Key Biomarkers and Predictors of Alzheimer’s Disease
Jangampalli Adi Pradeepkiran, Javaria Baig, Md Ariful Islam, et al.
Aging and Disease (2024)
Open Access | Times Cited: 14

Plasma phospho-tau217 as a predictive biomarker for Alzheimer’s disease in a large south American cohort
Neetesh Pandey, Zikun Yang, Basilio Cieza, et al.
Alzheimer s Research & Therapy (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1

Biomarkers for Alzheimer’s Disease: Context of Use, Qualification, and Roadmap for Clinical Implementation
Jeffrey L. Cummings, Jefferson W. Kinney
Medicina (2022) Vol. 58, Iss. 7, pp. 952-952
Open Access | Times Cited: 33

Potential therapeutic use of plant flavonoids in AD and PD
Sun Meng-zhen, Li Ju, Lanchun Zhang, et al.
Heliyon (2022) Vol. 8, Iss. 11, pp. e11440-e11440
Open Access | Times Cited: 31

A comparison between tau and amyloid-β cerebrospinal fluid biomarkers in chronic traumatic encephalopathy and Alzheimer disease
Katherine W. Turk, Alexandra Geada, Victor E. Alvarez, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 28

Biomarkers of Dementia with Lewy Bodies: Differential Diagnostic with Alzheimer’s Disease
Olivier Bousiges, Frédéric Blanc
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6371-6371
Open Access | Times Cited: 28

Biomarkers: Role and Scope in Neurological Disorders
Vivek Sharma, Thakur Gurjeet Singh, Vineet Mehta, et al.
Neurochemical Research (2023) Vol. 48, Iss. 7, pp. 2029-2058
Closed Access | Times Cited: 17

Cerebrospinal fluid: A specific biofluid for the biosensing of Alzheimer's diseases biomarkers
Arezoo Mirzaie, Hassan Nasrollahpour, Balal Khalilzadeh, et al.
TrAC Trends in Analytical Chemistry (2023) Vol. 166, pp. 117174-117174
Closed Access | Times Cited: 17

Biomarkers associated with the pathogenesis of Alzheimer’s disease
Hui Wang, Mengli Sun, Wenhui Li, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 16

Comparative analysis of machine learning algorithms for Alzheimer's disease classification using EEG signals and genetic information
Wei-Yang Yu, Ting-Hsuan Sun, Kai-Cheng Hsu, et al.
Computers in Biology and Medicine (2024) Vol. 176, pp. 108621-108621
Closed Access | Times Cited: 6

Peripheral Blood and Cerebrospinal Fluid Levels of YKL-40 in Alzheimer’s Disease: A Systematic Review and Meta-Analysis
Yuchen Zhang, Jinzhou Tian, Jingnian Ni, et al.
Brain Sciences (2023) Vol. 13, Iss. 10, pp. 1364-1364
Open Access | Times Cited: 14

Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases
Madelene Braun, Gustaf Boström, Martin Ingelsson, et al.
Fluids and Barriers of the CNS (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 14

Enhanced Terahertz Specific Sensing for Alzheimer’s Marker by Metasurface-Analyte Union Modification on Microfluidic Sensor
Weinan Shi, Fei Fan, Shanshan Li, et al.
IEEE Sensors Journal (2024) Vol. 24, Iss. 6, pp. 7690-7699
Closed Access | Times Cited: 5

Peripheral Single‐Cell Immune Characteristics Contribute to the Diagnosis of Alzheimer's Disease and Dementia With Lewy Bodies
Conglong Qiu, Danhua Zhang, Majie Wang, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 1
Open Access

An Overview of Transgenic Mouse Models for the Study of Alzheimer’s Disease
Paula A. Lopes, Mafalda Soares Pádua, José Luis Guil‐Guerrero
Journal of dementia and Alzheimer's disease (2025) Vol. 2, Iss. 1, pp. 2-2
Open Access

The Common Alzheimer's Disease Research Ontology (CADRO) for biomarker categorization
Amanda M. Leisgang Osse, Jefferson W. Kinney, Jeffrey L. Cummings
Alzheimer s & Dementia Translational Research & Clinical Interventions (2025) Vol. 11, Iss. 1
Open Access

Review on computational methods for the detection and classification of Parkinson's Disease
Komal Singh, Manish Khare, Ashish Khare, et al.
Computers in Biology and Medicine (2025) Vol. 187, pp. 109767-109767
Closed Access

Page 1 - Next Page

Scroll to top